SCHEMBL19784436

SCHEMBL19784436

NCc1ccc(-c2ccc(C(C=O)c3ccccc3)cc2)s1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2E1 P05181 5/20 0.61
CYP3A4 P08684 5/20 0.61
CYP2A6 P11509 5/20 0.61
CYP2C9 P11712 4/20 0.61
CYP2B6 P20813 4/20 0.61
CYP2C19 P33261 4/20 0.61
CYP2D6 P10635 3/20 0.43
CYP1A2 P05177 2/20 0.40
CYP2C8 P10632 2/20 0.40
RORC P51449 1/20 0.40
LOX P28300 6/20 0.40
LTA4H P09960 1/20 0.40
LOXL2 Q9Y4K0 2/20 0.37
MAOA P21397 1/20 0.37
HPGDS O60760 1/20 0.37
CHRNB2 P17787 1/20 0.37
CHRNA4 P43681 1/20 0.37
NQO2 P16083 1/20 0.35
APP P05067 1/20 0.34
HDAC3 O15379 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2690207 0.78 CYP2E1 (1.00) CYP2E1CYP3A4CYP2A6CYP2C9CYP2B6
Hydrochloric Acid SCHEMBL31558446 0.76 CYP2A6 (0.96) CYP2E1CYP3A4CYP2A6CYP2C9CYP2B6
SCHEMBL1515909 0.72 ACP3 (0.48) CYP3A4CYP2D6CYP1A2MAOAHPGDS
SCHEMBL13368895 0.70 ACP3 (0.47) CYP3A4CYP1A2CHRNB2CHRNA4
SCHEMBL193931 0.70 CYP2D6 (0.48) CYP3A4CYP2A6CYP2D6
SCHEMBL19784056 0.69 CHRNB2 (0.40) LOXL2CHRNB2CHRNA4
SCHEMBL4411621 0.68 CYP2A6 (0.66) CYP2E1CYP3A4CYP2A6CYP2C9CYP2B6
SCHEMBL19531540 0.68 CYP2A6 (0.66) CYP2E1CYP3A4CYP2A6CYP2C9CYP2B6
SCHEMBL6438203 0.67 TSHR (0.42) CYP3A4CYP2C9CYP2C19CYP2D6CYP1A2
Hydrochloric Acid SCHEMBL2886707 0.66 CYP2A6 (0.63) CYP2E1CYP3A4CYP2A6CYP2C9CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018011090-A1 HYDROXYQUINOLINONE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARMACEUTICI S.P.A. (IT) 2018-01-18 WO disclosed